Sep 8, 2026GLP-1 prescriptions for children have surged more than 30,000% since 2019, underscoring rapid growth in pediatric use of drugs like Novo Nordisk's Wegovy.

Sep 7, 2026Novo Nordisk's STEP Young trial shows once-weekly semaglutide plus lifestyle changes lifted 40.4% of children aged 6-11 with obesity out of the obesity category after 68 weeks.

Sep 7, 2026Novo Nordisk halts two more ziltivekimab heart-failure trials after a data monitor found limited likelihood of success, leaving only the ARTEMIS post-MI study active.

Coverage details

C 75%

R 25%

Left: 00%
Center: 375%
Right: 125%

Total sources4

Last updatedSep 9, 2026

Does this breakdown look right?

Sponsored

How it spread

Broke NewsNation · Sep 8, 10:27 AM ET→Center within the hour→Right within the hour→5 sources within the hour on

Claim check

What each side asserts, disputes — or leaves out entirely.

Analyzing the coverage…

Where do you land?

Whose framing of this story rings truest to you?

Sponsored

How each side headlines it

Left· 0 sources

No left coverage yet — a bubble gap.

Center· 3 sources

“GLP-1 prescriptions for kids up more than 30,000% since 2019”

NewsNation · Sep 8, 2026

Right· 1 source

“More kids age 8 to 11 are being prescribed weight loss drugs: study”

New York Post · Sep 8, 2026

Coverage

Sponsored

Comments

Ask Genius by OpenServe:

Free account · your comment posts right after signup

Sponsored